EMILY HAMMONDS: Open Payments
NPI 1083330971 · MC DOWELL, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,671 in 86 payments from 21 companies in 2025. Trend: 2023 $1,450 · 2024 $2,659 · 2025 $1,671
Food & beverage: $1,671
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 17 | $280 |
| AstraZeneca Pharmaceuticals LP | 11 | $226 |
| Takeda Pharmaceuticals U.S.A., Inc. | 6 | $143 |
| GlaxoSmithKline, LLC. | 5 | $118 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $109 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $101 |
| PFIZER INC. | 5 | $91 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $82 |
| Novartis Pharmaceuticals Corporation | 4 | $80 |
| Grifols USA, LLC | 3 | $62 |
Products named: TRINTELLIX, AIRSUPRA, TRELEGY ELLIPTA, Kerendia, QULIPTA, CAPLYTA, NURTEC ODT, FARXIGA.
Industry payments across KY — which companies pay providers there.
